Drug disposition in obesity and protein-energy malnutrition.

Drug disposition in obesity and protein-energy malnutrition.

Item
http://www.wikidata.org/entity/Q37778872
The effect of malnutrition on the pharmacokinetics and virologic outcomes of lopinavir, efavirenz and nevirapine in food insecure HIV-infected children in Tororo, UgandaMaternal protein restriction during lactation modulated the expression and activity of rat offspring hepatic CYP1A1, CYP1A2, CYP2B1, CYP2B2, and CYP2E1 during development.Pharmacokinetics of lopinavir/ritonavir and efavirenz in food insecure HIV-infected pregnant and breastfeeding women in Tororo, Uganda.Implications of obesity for drug therapy: limitations and challenges.Polypharmacy and food-drug interactions among older persons: a review.Body mass index is a prognostic factor in adult patients with acute myeloid leukemia.Effect of a high-fat diet on the hepatic expression of nuclear receptors and their target genes: relevance to drug disposition.Impact of pretransplant body mass index on the clinical outcome after allogeneic hematopoietic SCT.Drug and nutrition interactions: not just food for thought.Evaluation of Lean Body Weight Equation by Dual-Energy X-Ray Absorptiometry Measures.Impact of malnutrition on propofol consumption and recovery time among patients undergoing laparoscopic gastrointestinal surgery.Impact of body weight, low energy diet and gastric bypass on drug bioavailability, cardiovascular risk factors and metabolic biomarkers: protocol for an open, non-randomised, three-armed single centre study (COCKTAIL).
P2860

Drug disposition in obesity and protein-energy malnutrition.

Item
http://www.wikidata.org/entity/Q37778872
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Drug disposition in obesity and protein-energy malnutrition.
@en
Drug disposition in obesity and protein-energy malnutrition.
@nl
type
label
Drug disposition in obesity and protein-energy malnutrition.
@en
Drug disposition in obesity and protein-energy malnutrition.
@nl
prefLabel
Drug disposition in obesity and protein-energy malnutrition.
@en
Drug disposition in obesity and protein-energy malnutrition.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
Drug disposition in obesity and protein-energy malnutrition.
@en
P2093
P304
P31
P356
P433
P478
P577
P5875
P698
P921